---
title: "Medicus Pharma Ltd. (MDCX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/MDCX.US.md"
symbol: "MDCX.US"
name: "Medicus Pharma Ltd."
industry: "Biotechnology"
---

# Medicus Pharma Ltd. (MDCX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [medicuspharma.com](https://medicuspharma.com) |

## Company Profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic coll...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.09 | 193/606 | - | - | - |
| PB | -42.95 | 553/606 | 15.06 | 14.36 | 11.90 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-28T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 50% |
| Overweight | 1 | 25% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.53 |
| Highest Target | 27.00 |
| Lowest Target | 12.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/MDCX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/MDCX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/MDCX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.